Literature DB >> 24011674

The utility of routine preoperative cervical ultrasonography in patients undergoing thyroidectomy for differentiated thyroid cancer.

Kathleen O'Connell1, Tina W Yen, Francisco Quiroz, Douglas B Evans, Tracy S Wang.   

Abstract

BACKGROUND: Preoperative ultrasonography (US) is recommended in all patients with differentiated thyroid cancer (DTC) to evaluate for clinically occult metastatic lymphadenopathy. The purpose of this study was to examine the influence of preoperative US findings on the initial operative management of patients with DTC.
METHODS: This is a retrospective review of 70 patients with biopsy-proven DTC who underwent total thyroidectomy between February 2010 and January 2012. All patients underwent preoperative cervical US (thyroid, central, and lateral neck lymph node compartments).
RESULTS: Palpable lateral neck adenopathy was thought to be present in 5 (7%) of the 70 patients, but confirmed by US in only 3; 2 patients avoided lateral compartment neck dissection (LCND). Of 65 patients with no palpable lymphadenopathy, 14 (22%) had abnormal lymphadenopathy on preoperative US. All 14 patients underwent total thyroidectomy with central compartment neck dissection (CCND); 12 patients with abnormal US findings in the lateral compartment(s) also underwent LCND. Metastatic disease was confirmed in 13 (93%) of the 14 patients: 13 of 14 who underwent CCND and 11 (92%) of 12 who underwent LCND.
CONCLUSION: This study confirms the importance of preoperative, high-quality cervical US in patients with DTC because it changed the operative management in 16 of 70 patients (23%); 13 had a more complete operation for pathologically confirmed, clinically occult, lymph node metastases, 2 avoided nontherapeutic LCND, and 1 had false-positive US results.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24011674     DOI: 10.1016/j.surg.2013.06.040

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  10 in total

Review 1.  Controversial Issues in Thyroid Cancer Management.

Authors:  R Michael Tuttle
Journal:  J Nucl Med       Date:  2018-04-13       Impact factor: 10.057

2.  SEOM clinical guideline thyroid cancer (2019).

Authors:  E Gallardo; J Medina; J C Sánchez; A Viúdez; E Grande; I Porras; T Ramón Y Cajal; J Trigo; L Iglesias; J Capdevila
Journal:  Clin Transl Oncol       Date:  2020-01-31       Impact factor: 3.405

Review 3.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

4.  Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.

Authors:  Nathalie Chereau; Etienne Dauzier; Gaëlle Godiris-Petit; Séverine Noullet; Isabelle Brocheriou; Laurence Leenhardt; Camille Buffet; Fabrice Menegaux
Journal:  Langenbecks Arch Surg       Date:  2018-02-14       Impact factor: 3.445

5.  Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome.

Authors:  G Sapuppo; F Palermo; M Russo; M Tavarelli; R Masucci; S Squatrito; R Vigneri; G Pellegriti
Journal:  J Endocrinol Invest       Date:  2017-06-23       Impact factor: 4.256

6.  Machine Learning-Based Shear Wave Elastography Elastic Index (SWEEI) in Predicting Cervical Lymph Node Metastasis of Papillary Thyroid Microcarcinoma: A Comparative Analysis of Five Practical Prediction Models.

Authors:  Xue Huang; Yukun Zhang; Du He; Lin Lai; Jun Chen; Tao Zhang; Huilin Mao
Journal:  Cancer Manag Res       Date:  2022-09-21       Impact factor: 3.602

7.  Diagnostic accuracy of ultrasound, CT and their combination in detecting cervical lymph node metastasis in patients with papillary thyroid cancer: a systematic review and meta-analysis.

Authors:  Jian Yang; Fengyan Zhang; Ying Qiao
Journal:  BMJ Open       Date:  2022-07-04       Impact factor: 3.006

8.  Computed Tomography-Based Radiomics Model to Predict Central Cervical Lymph Node Metastases in Papillary Thyroid Carcinoma: A Multicenter Study.

Authors:  Jingjing Li; Xinxin Wu; Ning Mao; Guibin Zheng; Haicheng Zhang; Yakui Mou; Chuanliang Jia; Jia Mi; Xicheng Song
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-21       Impact factor: 5.555

9.  Expanded use of telemedicine for thyroid and parathyroid surgery in the COVID-19 era and beyond.

Authors:  Roger W Boles; Melissa Zheng; Daniel Kwon
Journal:  Am J Otolaryngol       Date:  2022-02-11       Impact factor: 1.808

10.  Recurrence rate in regional lymph nodes in 737 patients with follicular or Hürthle cell neoplasms.

Authors:  Andrej Vogrin; Hana Besic; Nikola Besic; Maja Marolt Music
Journal:  Radiol Oncol       Date:  2016-07-19       Impact factor: 2.991

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.